Peterson Neil W. 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
MMSI COO Neil Peterson Receives Stock Awards
What Happened
- Neil W. Peterson, Chief Operating Officer of Merit Medical Systems, received two equity awards on 2026-02-26: 7,690 restricted stock units (RSUs) and 17,002 shares issued following performance stock unit conditions — a total of 24,692 shares (granted at $0.00). On the same date he surrendered 6,061 shares of common stock to the company to satisfy payroll and income tax withholding obligations; those withheld shares were valued at $78.02 each for a withholding amount of $472,879. No open-market sale occurred.
Key Details
- Transaction date: 2026-02-26; Form 4 filed 2026-03-02 (timely)
- Awards: 7,690 RSUs (F1) and 17,002 performance-based shares (F2), granted/acquired at $0.00
- Tax withholding: 6,061 shares surrendered (F3) at $78.02/share, total $472,879 (Disposed)
- Shares owned after transaction: not specified in the filing
- Notable footnotes:
- F1: RSUs vest in three equal annual installments, subject to continued service; each RSU converts to one share on vesting.
- F2: 17,002 shares were issued after the Compensation & Talent Development Committee determined performance conditions were met for PSU awards granted 02/28/2023.
- F3: Shares were surrendered to cover payroll/income taxes; no open-market sale.
- F4/F5 (included in filing): related vesting schedules for other option grants (25% annual vesting schedules).
Context
- This filing reflects equity compensation and routine tax withholding rather than a directional buy or sell by the insider. The RSU and performance-share grants are acquisitions of company stock contingent on vesting/performance; the surrendered shares are a common cashless/tax-withholding mechanism and do not represent an open-market sale.
Insider Transaction Report
Form 4
Peterson Neil W.
CHIEF OPERATING OFFICER
Transactions
- Award
Common Stock, No Par Value
[F1]2026-02-26+7,690→ 36,059 total - Award
Common Stock, No Par Value
[F2]2026-02-26+17,002→ 53,061 total - Tax Payment
Common Stock, No Par Value
[F3]2026-02-26$78.02/sh−6,061$472,879→ 47,000 total
Holdings
- 25,000
Non-qualified stock options (right to buy)
[F4]Exercise: $68.33From: 2022-08-19Exp: 2028-08-19→ Common Stock (25,000 underlying) - 13,576
Non-qualified stock options (right to buy)
[F5]Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying)
Footnotes (5)
- [F1]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- [F2]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.
- [F3]The Reporting Person surrendered 6,061 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.
- [F4]Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
- [F5]Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Signature
/s/ Brian G.Lloyd, Attorney-in-Fact|2026-03-02